5.990USD-2.84%Mkt Cap: 1.04B USDP/E: 86.43Last update: 2026-06-01
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-u…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap1.04B USD
Enterprise Value1.21B USD
Revenue (TTM)314.85M USD
Gross Profit249.28M USD
Net Income (TTM)554.00K USD
Revenue/Share1.909 USD
Last Price5.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees435
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS98422E1038
Valuation
P/E (Trailing)86.43
P/E (Forward)15.59
PEG—
EV/EBITDA25.15
EV/Revenue3.84
P/S3.38
P/B75.12
EPS (TTM)0.07
EPS (Forward)0.40
52W Range
4.30029% of range10.08
52W High10.08 USD
52W Low4.300 USD
Profitability
Gross Margin85.41%
Oper. Margin9.52%
EBITDA Margin15.27%
Profit Margin0.19%
ROE4.05%
ROA0.14%
Growth
Revenue Growth38.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF28.63M USD
CapEx (TTM)696.00K USD
FCF Margin13.40%
FCF Yield4.04%
Net Debt146.80M USD
Net Debt/EBITDA3.05
Balance Sheet
Debt/Equity18.85
Current Ratio2.12
Quick Ratio1.42
Book Value/Sh0.0820 USD
Cash/Share0.6470 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)11.29 USD
Target Range8.000 USD – 18.00 USD
# Analysts7
Ownership
Shares Out.172.64M
Float163.84M
Insiders3.35%
Institutions62.28%
Short Interest
Short Ratio7.4d
Short % Float7.41%
Short % Out.7.16%
Shares Short12.36M
Short (prev mo.)15.74M
Technical
SMA 506.043 (-0.9%)
SMA 2007.123 (-15.9%)
Beta0.92
S&P 52W Chg27.70%
Avg Vol (30d)1.52M
Avg Vol (10d)1.33M
Technical Indicators
RSI (14)49.1
MACD0.0281
MACD Signal0.0412
MACD Hist.-0.0131
BB Upper6.602 USD
BB Middle6.274 USD
BB Lower5.946 USD
BB Width10.45%
ATR (14)0.2673 USD
Vol Ratio (20d)0.71x